Back to Search
Start Over
Neurophysiological Characteristics in Type II and Type III 5q Spinal Muscular Atrophy Patients: Impact of Nusinersen Treatment.
- Source :
- Drug Design, Development & Therapy; Mar2024, Vol. 18, p953-965, 13p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 11778881
- Volume :
- 18
- Database :
- Complementary Index
- Journal :
- Drug Design, Development & Therapy
- Publication Type :
- Academic Journal
- Accession number :
- 176616639
- Full Text :
- https://doi.org/10.2147/DDDT.S449066